General Information of This Drug (ID: DMLMOIJ)

Drug Name
Cyproterone acetate   DMLMOIJ
Synonyms
Cyprosterone acetate; Cyproteron acetate; Cyproteron-R acetate; Cyproterone 17-O-acetate; Cyproterone 17.alpha.-acetate; Cyproterone 17alpha-acetate; Cyproterone acetate [USAN:JAN]; Androcur; CYPROTERONE ACETATE; Cyproteroneacetate; SH 714; SH 80714; SH-714; 3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 17-(acetyloxy)-6-chloro-1,2-dihydro-, (1beta,2beta)-; 427-51-0; 4KM2BN5JHF; C24H29ClO4; CCRIS 4385; CHEBI:50743; CHEMBL139835; EINECS 207-048-3; HSDB 3592; MLS000859908; NSC 81430; NSC-81430; UNII-4KM2BN5JHF
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Cyproterone acetate + Ethinyl estradiol DCXXKRR Ethinyl estradiol Hyperandrogenism [1]
Cyproterone acetate + Triptorelin DCGA62Z Triptorelin Gender Dysphoria [2]
Cyproterone acetate + Estradiol DCN9CYR Estradiol Transsexualism [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02460445) Phlebotomy and Polycystic Ovary Syndrome
2 ClinicalTrials.gov (NCT02715232) Effects of Sex Steroids on the Serotonin System
3 ClinicalTrials.gov (NCT01065220) Sex Steroids and the Serotonin Transporter